Fenk R - Search Results

1

Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma.

Bogun L, Koch A, Scherer B, Fenk R, Maus U, Bormann F, Köhrer K, Petzsch P, Wachtmeister T, Zukovs R, Dietrich S, Haas R, Schroeder T, Jäger P, Geyh S. Bogun L, et al. Among authors: fenk r. Blood Adv. 2024 May 28;8(10):2575-2588. doi: 10.1182/bloodadvances.2023011632. Blood Adv. 2024. PMID: 38241490 Free PMC article.

2

Myasthenia gravis: selective enrichment of antiacetylcholine receptor antibody production in untransformed human B cell cultures.

Padberg F, Matsuda M, Fenk R, Patenge N, Kubuschok B, Hohlfeld R, Wekerle H, Spuler S. Padberg F, et al. Among authors: fenk r. Eur J Immunol. 1999 Nov;29(11):3538-48. doi: 10.1002/(SICI)1521-4141(199911)29:11<3538::AID-IMMU3538>3.0.CO;2-Y. Eur J Immunol. 1999. PMID: 10556808 Free article.

3

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.

Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators. Kastritis E, et al. N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631. N Engl J Med. 2021. PMID: 34192431 Clinical Trial.

4

IFN-alpha skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo.

Papewalis C, Jacobs B, Wuttke M, Ullrich E, Baehring T, Fenk R, Willenberg HS, Schinner S, Cohnen M, Seissler J, Zacharowski K, Scherbaum WA, Schott M. Papewalis C, et al. Among authors: fenk r. J Immunol. 2008 Feb 1;180(3):1462-70. doi: 10.4049/jimmunol.180.3.1462. J Immunol. 2008. PMID: 18209041 Clinical Trial.

5

Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma.

Kropff MH, Lang N, Bisping G, Dominé N, Innig G, Hentrich M, Mitterer M, Südhoff T, Fenk R, Straka C, Heinecke A, Koch OM, Ostermann H, Berdel WE, Kienast J. Kropff MH, et al. Among authors: fenk r. Br J Haematol. 2003 Aug;122(4):607-16. doi: 10.1046/j.1365-2141.2003.04473.x. Br J Haematol. 2003. PMID: 12899716 Free article. Clinical Trial.

6

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells.

Steidl U, Kronenwett R, Rohr UP, Fenk R, Kliszewski S, Maercker C, Neubert P, Aivado M, Koch J, Modlich O, Bojar H, Gattermann N, Haas R. Steidl U, et al. Among authors: fenk r. Blood. 2002 Mar 15;99(6):2037-44. doi: 10.1182/blood.v99.6.2037. Blood. 2002. PMID: 11877277 Free article.

7

Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma.

Tapprich C, Fenk R, Schneider P, Bernhardt A, Haas R, Kobbe G. Tapprich C, et al. Among authors: fenk r. Bone Marrow Transplant. 2003 Sep;32(6):629-31. doi: 10.1038/sj.bmt.1704183. Bone Marrow Transplant. 2003. PMID: 12953137

8

Molecular monitoring of minimal residual disease in patients with multiple myeloma.

Fenk R, Haas R, Kronenwett R. Fenk R, et al. Hematology. 2004 Feb;9(1):17-33. doi: 10.1080/10245330310001638965. Hematology. 2004. PMID: 14965865 Free article. Review.

9

Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators.

Steidl U, Bork S, Schaub S, Selbach O, Seres J, Aivado M, Schroeder T, Rohr UP, Fenk R, Kliszewski S, Maercker C, Neubert P, Bornstein SR, Haas HL, Kobbe G, Tenen DG, Haas R, Kronenwett R. Steidl U, et al. Among authors: fenk r. Blood. 2004 Jul 1;104(1):81-8. doi: 10.1182/blood-2004-01-0373. Epub 2004 Mar 11. Blood. 2004. PMID: 15016651 Free article.

10

Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma.

Fenk R, Ak M, Kobbe G, Steidl U, Arnold C, Korthals M, Hünerlitürkoglu A, Rohr UP, Kliszewski S, Bernhardt A, Haas R, Kronenwett R. Fenk R, et al. Haematologica. 2004 May;89(5):557-66. Haematologica. 2004. PMID: 15136219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters